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878-1 The PPAR-T Activator Troglitazone, but Not 
Rosiglitazone, Preserves Contractile Function and 
Suppresses Proinflammatory Cytokines in Myocardial 
lschemia and Reperfusion 
Michael W. Gen. Ya Xu, Li Lu, Hasan Ahmad, Daniel Perlov. Carlin S. Long, Gregory G. 
Schwartz. University of Colorado Health Sciences Center, Denver, CO, Denver VA 
MedIcal Center, Denver, CO 
Background: Activation of the nuclear receptor PPARy attenuates expression of pro- 
inflammatory cytokines. PPAR-y is expressed in myocardium and pro-inflammatory 
cytokines may contribute to myocardial dysfunction after ischemitireperfusion (I/R). We 
tested the hypothesis that PPAR-y actwators abrogate expression of cytokines in I/R, and 
preserve LV function. Methods: Non-diabetic pigs were pretreated with rosigfitazone 
@OS. 3 mgfkg/d) or troglitazone (TGZ. 75mgikgfd) for 8 wks. A control group (CON) 
received no pretreatment. Plasma concentrations of ROS and TGZ were similar to clini- 
cal levels. Each pig underwent 90 min low-flow ischemia and 90 min reperfusion. LV 
function was assessed by sonomicrometry. Expression of cytokines and PPAR-y were 
assessed by ribonuclease protection assay. Results: Baseline hemodynamics and 
severity of ischemia were similar in all arouos. After I/R. LV function was similarlv 
depressad In CON (23%*5) and ROS (21%;44). but was significantly greater in TG; 
(44%*5). Cvtokine exoression was also similar between CON and ROS hearts. and sio- ., 
mficantly less in TGZ hearts and non-ischemic myocardium (pc.01, Table). Conclusion: 
The PPAR-yactivator TGZ, but not ROS, preserves LV function and suppresses cyiokine 
expression after myocardial I/R. Different responses to ROS vs. TGZ may reflect expres- 
sion of different PPAR-responswe genes or effects of the non-thiazolidinedione moieties 
of each molecule. 
Group ILil3; 
Non-ischemic, n=18 0.026 
(0.006.0.074) 
I/R CON, n= 17 0.413 
(0.112,0.565) 
I/R ROS, n=lZ 0.275 
(0.245,0.305) 
I/R TGZ, n=5 0.008 
(0.007,0.016) 
IL6 
0.028 
(0.013,0.028) 
0.344 
(0.214,0.713) 
0.373 
(0.322,0.425) 
0.054 
(0.050.0.066) 
IFNy 
0.007 
(0.003,0.016) 
0.059 
(0.026.0.149) 
0.073 
(0.066,0.095) 
0.023 
(0.018,0.029) 
Median (25%,75%) normalized to GAPDH; * pc.05 vs non-ischemic 
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878-2 The Thyroid Hormone Analog, 3,5 Diiodothyropropionic 
Acid (DITPA) Restores Diminished Vascular Beta- 
Adrenergic and Endothelial Mediated Vasorelaxation in 
Heart Failure 
Peter H. Spooner, Steven Goldman, Mohamed A. Gaballa, University of Arizona Sawer 
Heart Center, Tucson, AZ Southern Arizona VA Health Care System, Tucson, AZ 
This study was designed to determine if the thyroid hormone analog 3,5 diiodothyropropi- 
onic acid (DITPA), which is being developed to treat heart failure, affects vascular func- 
tion. This is important because vascular reactivity is altered in heart failure via diminished 
endothelial dependent vasorelaxation and depressed response to beta-adrenergic 
receptor (PAR) stimulation, both systems in which thyroid hormone has been shown to 
have an effect. Myocardial infarction (Ml) was created in adult Sprague Da&y rats by 
ligating the left coronary altery Three weeks after ligation, rats were randomly assigned 
to DITPA or no treatment and sham or MI In a 2x2 factorial design DITPA 375@g/lW gm 
subcutaneous daily for 3 weeks. At ths end of the study. hemodynamics was measured 
and thoracic aortic rings were harvested for vasorelaxation studies. Cultured bovine pul- 
monary endothelial cells were exposed to DITPA for 24 hours and assayed for endothe- 
lial nitric oxide synthase (eNOS) levels. In isolated arterial segments from heart failure 
rats, DITPA enhanced the vasorelaxation response to acetylcholine (45% at 104 acetyl- 
choline, P=O.O38) and to isoproterenol (50% at lOA isoproterenol, P&05). DITPA. at 1 
NM, 10pM and 20pM, increased (P=O.o07) eNOS protem expression in cultured endot- 
helial cells from from a baseline value of 22 09k4.75, to 29.88&61, 52.72516.82 and 
49.09+15.20 lllmg protem. respectively. Thus. after myocardial infarction, DITPA 
enhances endothelial-mediated vasorelaxation through two mechanisms: 1) Increased 
responsiveness to @-AR stimulation and 2) Increased endothellal nitric oxide synthase 
resulting in Increased endothelial dependent vasodilatation and increased NO availability 
in the endothellum. It is possible that the vascular action of DITPA IS medlated through,?- 
AR stimulation, which in turn increases nitric oxide release in the endothelium. 
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878-3 Deletion of Kir6.2 Worsens Diastolic Dysfunction in the 
Stunned Myocardium 
Richard J. Gumina, Christopher E. Kurtz, Peter Bast, Denice Hodgson, Fergus 
O’Coclain, Takashi Miki, Susumu Seine, Andre Terzic. Mayo Clinic and Foundation, 
Rochester, MN 
Background: Sarcolemmal ATP-sensitive potassium (KATP) channels regulate cardiac 
response to stress by supporting calcium homeostasis. However, their role in protection 
from myocardial stunning, a condition associated with dysregulated calcium handling, 
has not been defined. 
Methods: Isolated hearts from wild-type (WT) or Kir6.2.knockout (KO) mice lacking 
Kir6.2. the pore-forming subunit of sarcolemmal KATP channels, were paced at 500 bpm 
and perfused on a Langendodf apparatus for 30 min, then subjected to 10 min of zero- 
flow normothermic &hernia followed by a 30 min-long reperfuslon. Contractile parame- 
ters ware derived from a balloon pressure transducer. Coronay effluents were collected 
for determination of creatine kinase release. ANOVA comparison of means was used for 
statistical analysis. 
Results: On rep&u&n, creatine kinase leakage was negligible and comparable in both 
WT and KO hearts, indicative of non-lethal injury. Characteristic of stunning, WT hearts 
exhiblted a transient reduction in contractile performance measured by rate-pressure 
product and left ventricular end-diastolic pressure (LVEDP: 4.3eO.5 prior to ischemia vs. 
16.4t3.6 and 7.Ok2.1 mmHg at 2.5 and 30 min reperfusion). KO hearts demonstrated a 
more pronounced reduction in RPP accompanied with protracted elevation in LVEDP 
(8.5*1 .O prior to ischemia vs. 34.Oe2.4 and 21.8+ 5.4 mmHg at 2.5 and 30 min reperfu- 
sion). Treatment with the calciumlcalmodulin antagonist W7 abrogated excessive dias- 
tolic dysfunction observed in KO mice, wth a reduction in LVEDP to 21*1 .O and 11.8+0.6 
mmHg at 2.5 and 30 min repetiusion, respectively. 
Conclusion: Knockout of sarcolemmal KATP channels aggravates myocardial stunning 
due to excessive calcium mishandling, resulting in diastolic dysfunction 
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878-4 Apoptosis and DNA Damage Markers in Human Left 
Ventricular Samples Under Controlled lschemia and 
Reperfusion 
Cinzia Perrino, Ciro Indolfi, Gian Giacomo Corbucci, Andrea Ricchi, Giuseppe Donate, 
Enrico Vittorio Awedimento, Massimo Chiariello. Universltv Federico Il. Naoles. Italv. 
Brotzu Hospital, Caghari. Italy 
1 .  
Background Apoptosis has been implicated in in vm animal models of myocardial 
Ischemia-reperfusion and in progressive deterioration of cardiac function. Cardiopulmo- 
nary bypass during cardiac surgery is a controlled human model of myocardial ischemia 
and repelfuslon injury. Methods Human left ventricular samples were taken from 16 
patients undergoing elective valvular surgery (1) before aoriic cross-clamping; (2) 20+2 
minutes (brief ischemia) and (3) 58~5 minutes after cross-clamplng (prolonged 
ischemia); and (4) 21r4 minutes after reconstitution of coronary blood flow (reperfusion). 
Western Blotting were performed in samples from 10 patients to evaluate Mitogen Acti- 
vated Protein Kinases (MAPKs) activation, caspase 3 and 9 activation, ~53 and p21WAF 
protein levels. Left ventncular specimens from 6 patients were subjected to Hematossilin- 
Eosin (HE) and TUNEL staining, Electronic Microscope (EM). Results Brief and pro- 
longed ischemia induced rapid activation of caspase 3 and p531p21wAF. Caspase 3 acti- 
vation was associated to a strong TUNEL signal in nearly 40% of the cells. The staining 
of the same cells with HE did not show morphological changes. EM of the samples 
showed that only in approximately 5% of the cells there ware morphological signs of apo- 
ptosis. More than 80% of the cells showed mitochondrial swelling. Reperfusion was 
associated with significant MAPKs (ERK, Jun, ~38) and mitochondrial caspase 9 activa- 
tion, with still high caspase 3 activation, TUNEL positivity and high p53ip21 WAFle~els. 
HE and ME confirmed the presence of rare changes suggestwe of apoptosis. Finally, we 
found in ischemic and reperfused tissues phosphoylation of Histone H2. which marks 
double strand DNA breaks. Conclusions Myocardial ischemia induces a potent and 
rapid activation of caspase 3, which is potentiated by reperfusion, with mitochondrial 
caspase 9 actwation. Majority of the cells become TUNEL positive during ischemla, 
although morphological signs of apoptosis are present only in 5% of the cells by EM. His- 
tone 2 phosphorylation and ~531~21 activation indicate that ischemia-reperfusion induce 
extensive DNA damage and activate the repair system, apoptosis develops in a minortty 
Of cells 
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878-5 lntracoronary Delivery of Bone Marrow-Derived CD34+ 
Mononuclear Cells Increases Vascular Density in 
Infarcted Myocardium 
Julia N. Sunkomat, Mohamed A. Gaballa, University of Arizona Salver Heari Center, 
Tucson, AZ 
Previous studies demonstrated that necrotic tissue after myocardial infarction can be 
populated with neovessels and cardiomyocytes using intramyocardial injection of specific 
subtypes of adult bone marrow steml progenitor cells. However. this technique may not 
be practical in the clinical setting. In one study. bone marrow stromal cells delivered intra- 
coronary in infarcted myocardium underwent milieu-dependent differentiation into cardi- 
omyocytes and endocardial and capillary endothelial cells. Since bone marrow stromal 
cells contain several subtypes of stem/progenitor cells, it is unclear which subset of bone 
marrow cells differentiate into cardiac cells or vascular endothelial cells. Progenitor 
endothelial cells, CD34’ mononuclear cells (MNCs). were prewously shown to incorpo- 
